Catheter Precision, Inc. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
Catheter Precision, Inc. (VTAK) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $1.22 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2024-04-01
- Catheter Precision, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2023-03-31 was $1.39M, a 744.85% increase year-over-year.
- Catheter Precision, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2022-09-30 was $74.00K.
- Catheter Precision, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2022-06-30 was $126.00K.
- Catheter Precision, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2022-03-31 was $165.00K.
- Catheter Precision, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2023 was $1.22M, a 172.26% increase from fiscal 2022.
- Catheter Precision, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2022 was $447.00K.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2023-12-31 | $1.22M 10-K · filed 2024-04-01 | |||
| 2023-03-31 | $1.39M 10-Q · filed 2023-12-15 | |||
| 2022-12-31 | $447.00K 10-K · filed 2024-04-01 | |||
| 2022-09-30 | $74.00K 10-Q · filed 2023-12-21 | $200.00K derived: sum of 2 quarters · filed 2023-12-21 | $365.00K derived: sum of 3 quarters · filed 2023-12-21 | |
| 2022-06-30 | $126.00K 10-Q · filed 2023-12-21 | $291.00K derived: sum of 2 quarters · filed 2023-12-21 | ||
| 2022-03-31 | $165.00K 10-Q · filed 2023-12-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |